PDGFRB and breast carcinoma: Nanoliposomes targeted against platelet-derived growth factor receptor (PDGFR) that contain IO-NPs, glucose oxidase and platinum increased ROS production and induced apoptosis/ferroptosis. Treatment of mice with a breast cancer xenograft (MDA-MB-231) reduced tumor size.